维普中文期刊产品整合服务
24篇 您的检索式:作者名="Deandreis"
    题名 作者 年代 出处 被引量
1Role of whole body positron emission tomography/eomputed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site显示文摘Pelosi E Pennone M Deandreis D 2006Q J Nucl Med Mol Imaging2006,50,1:1
2Is 18F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology显示文摘Deandreis D Al Ghuzlan A Auperin A 0,,2:1
3Role of whole body positron emission tomography/computed tomography scan with ^18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site 显示文摘Pelosi E Pennone M Deandreis D 2006Q J Nucl Med Mol Imaging2006,50,1:1
4Galectin-3:presurgical marker of thyroid follicular epithelial cell-derived carcinomas显示文摘Saggiorato E Aversa S Deandreis D 2004J Endocrinol2004,27,4:1
5Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site显示文摘Pelosi E Pennone M Deandreis D 2006QJ Nucl Med Mol Imaging2006,50,1:1
6FDG-PET in the detection of bone marrow disease in Hodgkin’s disease and aggressive non-Hodgkin’s lymphoma and its impact on clinical management显示文摘Pelosi E Penna D Deandreis D Chiappella A Skanjeti A Vitolo U Bisi G 2008The Quarterly Journal of Nuclear Medicine and Molecular Imaging2008,,1:1
7The role of 18F-fluoro-deoxy- glucose- positron ernission tomography (FDG-PET) in the management of patients with eolorectal cancer显示文摘Pelosi E Deandreis D 2007Eur J Surg Oncol2007,33,1:1
88F- fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer显示文摘Poisson T Deandreis D Leboulleux S 2010Eur J Nucl Med Mol Imaging2010,37,12:1
9Is (18) fflu- orodeoxyglucose+PET/CT useful for the presurgical character- ization of thyroid nodules with indeterminate fine needle aspira- tion cytology 显示文摘Deandreis D Al Ghuzlan A Auperin A 2012Thyroid2012,22,2:1
10Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site显示文摘Pelosi E Pennone M Deandreis D 2006Q J Nucl Med Mol Imag- ing2006,50,1:1
11Role of whole body positron emission tomography/computed tomography scan with ^18F- fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site 显示文摘Pelosi E Pennone M Deandreis D 2006Q J Nucl Med Mol Imaging2006,50,1:1
12Role of FDG PET/CT and chest CT in the follow-up of hmg lesions treated with radiofrequency ablation 显示文摘DEANDREIS D LEBOULLEUX S DROMAIN C 2011Radiology2011,258,1:1
13FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management显示文摘Pelosi E Penna D Deandreis D 2008Q J Nucl Med Mol Imaging2008,52,1:1
14Is (18) Ffluorodeoxyglucose -PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? 显示文摘Deandreis D Al Ghuzlan A Auperin A 2012Thyroid2012,22,2:1
15Role of whole body positron emission tomography/computed tomography scan with ^18F- fluorode- oxyglucose in patients with biopsy proven tumor metastases from unknown primary site显示文摘Pelosi E Pennone M Deandreis D 2006Q J Nucl Med Mol Imaging2006,1,:1
16Role of whole body positron emission tomography/computed tomography scan with 《'18》F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site显示文摘Pelosi E Pennone M Deandreis D 2006Q J Nucl Med Mol Imaging2006,50,1:1
17Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site显示文摘Pelosi E Pennone M Deandreis D 2006Q J Nucl Med Mol Imaging2006,50,1:1
18FOG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive nonHodgkin's lympboma and its impact on clinical management显示文摘Pelosi E Penna 0 Deandreis 0 2008Q J Nucl Med Mol Imaging2008,52,1:1
19Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis显示文摘Leboulleux S Deandreis D A1 Ghuzlan A 2010Eur J Endocrinol2010,162,6:1
20Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases form unknown primary site显示文摘Pelosi E Pennone M Deandreis D 0,,01:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费